Form 8-K - Current report:
SEC Accession No. 0001326190-25-000050
Filing Date
2025-09-25
Accepted
2025-09-25 16:07:15
Documents
12
Period of Report
2025-09-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K alt-20250925x8k.htm   iXBRL 8-K 81276
  Complete submission text file 0001326190-25-000050.txt   195324

Data Files

Seq Description Document Type Size
2 EX-101.SCH alt-20250925.xsd EX-101.SCH 3267
3 EX-101.LAB alt-20250925_lab.xml EX-101.LAB 15900
4 EX-101.PRE alt-20250925_pre.xml EX-101.PRE 10113
14 EXTRACTED XBRL INSTANCE DOCUMENT alt-20250925x8k_htm.xml XML 4868
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 251343778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)